Provided by Tiger Trade Technology Pte. Ltd.

Biogen

217.15
+1.720.80%
Pre-market: 217.400.2500+0.12%09:14 EDT
Volume:1.08M
Turnover:233.98M
Market Cap:32.06B
PE:38.57
High:219.76
Open:216.75
Low:214.71
Close:215.43
52wk High:225.80
52wk Low:135.39
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.65
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.70
PE(LYR):24.70

Loading ...

Biogen : Citigroup Raises Target Price to $215 from $200

THOMSON REUTERS
·
Aug 03

Stifel Nicolaus Remains a Buy on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Biogen, Inc : H.c. Wainwright Raises Target Price to $251 from $237

THOMSON REUTERS
·
Jul 30

Biogen is Maintained at Neutral by Wedbush

Dow Jones
·
Jul 30

Biogen price target lowered to $240 from $242 at RBC Capital

TIPRANKS
·
Jul 30

Alnylam Q2 Revenue Rises 67% on Increased Demand for Amvuttra

Reuters
·
Jul 30

Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Revenue Rises 71% on Rezdiffra Demand

Reuters
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30

Agios Q2 Revenue Jumps on US Commercial Launch of Aqvesme

Reuters
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

Biogen : TD Cowen Raises Target Price to $225 from $215

THOMSON REUTERS
·
Jul 30

Analysts’ Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)

TIPRANKS
·
Jul 30

Viking Therapeutics Reports Q2 Milder-than-expected Net Loss as Obesity Trials Advance

Reuters
·
Jul 30

Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook

Reuters
·
Jul 30

Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio

Benzinga Earnings
·
Jul 30

Analysts Conflicted on These Healthcare Names: Biogen (BIIB), NeuroPace (NPCE) and Gilead Sciences (GILD)

TIPRANKS
·
Jul 30

Wedbush Adjusts Biogen Price Target to $215 From $201, Maintains Neutral Rating

MT Newswires Live
·
Jul 30